MultiValent Biotherapies
MultiValent Biotherapies is a startup headquartered in Los Altos, United States, founded in 2025. It has raised at least $10.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
MultiValent Biotherapies has raised at least $10.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
MultiValent Biotherapies sits inside the Silicon Valley and the Bay Area R&D ecosystem in the Global R&D Labs Directory.
Other startups in Los Altos
- Anetac
- Brief Productivity Solutions
- Brisk Labs
- Bryte Labs
- FirstShift
- Maxymune Therapeutics
- Modulo Bio
- Novellus Holdings
Related
- Innovation profile of Los Altos
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does MultiValent Biotherapies do?
MultiValent Biotherapies is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has MultiValent Biotherapies raised?
At least $10.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is MultiValent Biotherapies based?
MultiValent Biotherapies is headquartered in Los Altos, United States.
When was MultiValent Biotherapies founded?
MultiValent Biotherapies was founded in 2025.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.